Risk factors for the onset of cervical intraepithelial neoplasia

Abstract

BACKGROUND: Persistent human papillomavirus (HPV) infection is a well-established cause of cervical intraepithelial neoplasia (CIN). Epidemiological studies show that while HPV infection is common, it is far more prevalent than CIN itself. Consequently, HPV testing exhibits moderate specificity and positive predictive value for detecting high-grade CIN. Currently, there is no optimal strategy for identifying HPV-positive women at high risk of CIN.

AIM: This study aims to assess the socioeconomic, behavioral, and comorbidity factors associated with an increased risk of developing cervical intraepithelial neoplasia.

MATERIAL AND METHODS: The study included 121 women who presented to the Medical Research and Education Center of Moscow State University in the period from 2022 to 2023. Pap-smear revealed normal data in 66 women (Group 1, NILM), mild cervical intraepithelial neoplasia in 27 (Group 2, LSIL), and severe cervical intraepithelial neoplasia in 28 (Group 3, HSIL). A comparative analysis of clinical data and medical history, data of liquid cytology and HPV typing was performed in all patients. Statistical analysis was performed using the MedCalc software package.

RESULTS: The analysis showed that the risk of severe cervical intraepithelial neoplasia increased 5.4-fold in patients aged >30 years, 3.4-fold in smokers, 9.9-fold in patients who had been sexually active for more than 10 years, 6.3-fold in patients who had ≥4 sexual partners, 4.1-fold in patients who used withdrawal method of contraception (coitus interruptus), 7.0-fold in patients who had ≥3 pregnancies, 4.7-fold in patients with HPV infection (in particular, 4.3-fold in women infected with HPV 16). Patients with cervical intraepithelial neoplasia had significantly greater probability to be infected with high-risk HPV types (88.9% in patients with LSIL and 85.7% in patients with HSIL vs. 56.1% in NILM women), in particular, HPV 16 was detected in more than half of patients with HSIL.

CONCLUSION: In this study sample, the risk of cervical intraepithelial neoplasia was associated with age over 30 years, smoking, duration of the sexual activity >10 years, number of sexual partners (>4), lack of barrier contraception, number of past pregnancies (>3), and persisting high-risk HPV infection, especially HPV 16.

Keywords

human papillomavirus / cervical intraepithelial neoplasia / cervical cancer / risk factors

References

[1] Singh D, Vignat J, Lorenzoni V, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO global cervical cancer elimination initiative. Lancet Glob Health. 2023;11(2):e197–e206. doi: 10.1016/S2214-109X(22)00501-0

[2] Singh D., Vignat J., Lorenzoni V., et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO global cervical cancer elimination initiative // Lancet Glob Health. 2023. Vol. 11, N 2. P. e197–e206. doi: 10.1016/S2214-109X(22)00501-0

[3] Singh D, Vignat J, Lorenzoni V, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO global cervical cancer elimination initiative. Lancet Glob Health. 2023;11(2):e197–e206. doi: 10.1016/S2214-109X(22)00501-0

[4] Kaczmarek M, Baj-Krzyworzeka M, Bogucki Ł, Dutsch-Wicherek M. HPV-related cervical cancer and extracellular vesicles. Diagnostics. 2022;12(11):2584. doi: 10.3390/diagnostics12112584

[5] Kaczmarek M., Baj-Krzyworzeka M., Bogucki Ł., Dutsch-Wicherek M. HPV-related cervical cancer and extracellular vesicles // Diagnostics. 2022. Vol. 12, N 11. P. 2584. doi: 10.3390/diagnostics12112584

[6] Kaczmarek M, Baj-Krzyworzeka M, Bogucki Ł, Dutsch-Wicherek M. HPV-related cervical cancer and extracellular vesicles. Diagnostics. 2022;12(11):2584. doi: 10.3390/diagnostics12112584

[7] Ershov VA. Concepts of the genesis of HPV-associated cervical cancer. Russian News of Clinical Cytology. 2021;25(1):20–29. EDN: KTZKMN doi: 10.24412/1562-4943-2021-1-0004

[8] Ершов В.А. Концепции генеза ВПЧ-ассоциированной цервикальной неоплазии // Новости клинической цитологии России. 2021. Т. 25, № 1. С. 20–29. EDN: KTZKMN doi: 10.24412/1562-4943-2021-1-0004

[9] Ershov VA. Concepts of the genesis of HPV-associated cervical cancer. Russian News of Clinical Cytology. 2021;25(1):20–29. EDN: KTZKMN doi: 10.24412/1562-4943-2021-1-0004

[10] Faizuloev EB, Kaira AN, Uzbekov TR, et al. The prevalence of high- and low-risk human papillomaviruses in the Russian Federation. Molecular Genetics, Microbiology and Virology. 2021;39(4):39–47. EDN: BJPTLV doi: 10.17116/molgen20213904139

[11] Файзулоев Е.Б., Каира А.Н., Узбеков Т.Р., и др. Распространённость папилломавирусов человека высокого и низкого онкогенного риска на территории Российской Федерации // Молекулярная генетика, микробиология и вирусология. 2021. Т. 39, № 4. С. 39–47. EDN: BJPTLV doi: 10.17116/molgen20213904139

[12] Faizuloev EB, Kaira AN, Uzbekov TR, et al. The prevalence of high- and low-risk human papillomaviruses in the Russian Federation. Molecular Genetics, Microbiology and Virology. 2021;39(4):39–47. EDN: BJPTLV doi: 10.17116/molgen20213904139

[13] Bogani G, Taverna F, Lombardo C, et al. Retrospective study of the influence of HPV persistence on outcomes among women with high-risk HPV infections and negative cytology. Int J Gynaecol Obstet. 2017;138(1):62–68. doi: 10.1002/ijgo.12170

[14] Bogani G., Taverna F., Lombardo C., et al. Retrospective study of the influence of HPV persistence on outcomes among women with high-risk HPV infections and negative cytology // Int J Gynaecol Obstet. 2017. Vol. 138, N 1. P. 62–68. doi: 10.1002/ijgo.12170

[15] Bogani G, Taverna F, Lombardo C, et al. Retrospective study of the influence of HPV persistence on outcomes among women with high-risk HPV infections and negative cytology. Int J Gynaecol Obstet. 2017;138(1):62–68. doi: 10.1002/ijgo.12170

[16] Prisyazhnaya TS, Mikhaylyukova VA, Berlev IV, Malek AV. Risk factors modulating the course of low-grade squamous intraepithelial lesions in women of reproductive age. Tumors of the Female Reproductive System. 2021;17(1):45–52. EDN: MLWJSR doi: 0.17650/1994-4098-2021-17-1-45-52

[17] Присяжная Т.С., Михайлюкова В.А., Берлев И.В., Малек А.В. Факторы риска, модулирующие течение плоскоклеточных интраэпителиальных поражений низкой степени у женщин репродуктивного возраста // Опухоли женской репродуктивной системы. 2021. Т. 17, № 1. С. 45–52. EDN: MLWJSR doi: 0.17650/1994-4098-2021-17-1-45-52

[18] Prisyazhnaya TS, Mikhaylyukova VA, Berlev IV, Malek AV. Risk factors modulating the course of low-grade squamous intraepithelial lesions in women of reproductive age. Tumors of the Female Reproductive System. 2021;17(1):45–52. EDN: MLWJSR doi: 0.17650/1994-4098-2021-17-1-45-52

[19] Bowden SJ, Doulgeraki T, Bouras E, et al. Risk factors for human papillomavirus infection, cervical intraepithelial neoplasia and cervical cancer: an umbrella review and follow-up Mendelian randomisation studies. BMC Medicine. 2023;21(1):274. doi: 10.1186/s12916-023-02965-w

[20] Bowden S.J., Doulgeraki T., Bouras E., et al. Risk factors for human papillomavirus infection, cervical intraepithelial neoplasia and cervical cancer: an umbrella review and follow-up Mendelian randomisation studies // BMC Medicine. 2023. Vol. 21, N 1. P. 274. doi: 10.1186/s12916-023-02965-w

[21] Bowden SJ, Doulgeraki T, Bouras E, et al. Risk factors for human papillomavirus infection, cervical intraepithelial neoplasia and cervical cancer: an umbrella review and follow-up Mendelian randomisation studies. BMC Medicine. 2023;21(1):274. doi: 10.1186/s12916-023-02965-w

[22] Hortlund M, Mol T, Pol FV, et al. Human papillomavirus load and genotype analysis improves the prediction of invasive cervical cancer. Int J Cancer. 2021;149(3):684–691. doi: 10.1002/ijc.33519

[23] Hortlund M., Mol T., Pol F.V., et al. Human papillomavirus load and genotype analysis improves the prediction of invasive cervical cancer // Int J Cancer. 2021. Vol. 149, N 3. P. 684–691. doi: 10.1002/ijc.33519

[24] Hortlund M, Mol T, Pol FV, et al. Human papillomavirus load and genotype analysis improves the prediction of invasive cervical cancer. Int J Cancer. 2021;149(3):684–691. doi: 10.1002/ijc.33519

[25] Lam JUH, Rebolj M, Dugue PA, et al. Condom use in prevention of human papillomavirus infections and cervical neoplasia: systematic review of longitudinal studies. J Med Screen. 2014;21(1):38–50. doi: 10.1177/0969141314522454

[26] Lam J.U.H., Rebolj M., Dugue P.A., et al. Condom use in prevention of human papillomavirus infections and cervical neoplasia: systematic review of longitudinal studies // J Med Screen. 2014. Vol. 21, N 1. P. 38–50. doi: 10.1177/0969141314522454

[27] Lam JUH, Rebolj M, Dugue PA, et al. Condom use in prevention of human papillomavirus infections and cervical neoplasia: systematic review of longitudinal studies. J Med Screen. 2014;21(1):38–50. doi: 10.1177/0969141314522454

[28] Order of the Ministry of Health of the Russian Federation dated 10/20/2020 No. 1130n “On approval of the Procedure for providing medical care in the field of obstetrics and gynecology”. Publication number: 0001202011130037. Date of publication: 11/13/2020. Available from: http://publication.pravo.gov.ru/Document/View/0001202011130037 (In Russ.)

[29] Приказ Минздрава России от 20.10.2020 г. № 1130н «Об утверждении Порядка оказания медицинской помощи по профилю «акушерство и гинекология». Номер опубликования: 0001202011130037. Дата опубликования: 13.11.2020. Режим доступа: http://publication.pravo.gov.ru/Document/View/0001202011130037

[30] Order of the Ministry of Health of the Russian Federation dated 10/20/2020 No. 1130n “On approval of the Procedure for providing medical care in the field of obstetrics and gynecology”. Publication number: 0001202011130037. Date of publication: 11/13/2020. Available from: http://publication.pravo.gov.ru/Document/View/0001202011130037 (In Russ.)

[31] Feng Q, Balasubramanian A, Hawes SE, et al. Detection of hypermethylated genes in women with and without cervical neoplasia. J Natl Cancer Inst. 2005;97(4):273–282. doi: 10.1093/JNCI/DJI041

[32] Feng Q., Balasubramanian A., Hawes S.E., et al. Detection of hypermethylated genes in women with and without cervical neoplasia // J Natl Cancer Inst. 2005. Vol. 97, N 4. Р. 273–282. doi: 10.1093/JNCI/DJI041

[33] Feng Q, Balasubramanian A, Hawes SE, et al. Detection of hypermethylated genes in women with and without cervical neoplasia. J Natl Cancer Inst. 2005;97(4):273–282. doi: 10.1093/JNCI/DJI041

[34] Wei L, Griego AM, Chu M, Ozbun MA. Tobacco exposure results in increased E6 and E7 oncogene expression, DNA damage and mutation rates in cells maintaining episomal human papillomavirus 16 genomes. Carcinogenesis. 2014;35(10): 2373–2381. doi: 10.1093/carcin/bgu156

[35] Wei L., Griego A.M., Chu M., Ozbun M.A. Tobacco exposure results in increased E6 and E7 oncogene expression, DNA damage and mutation rates in cells maintaining episomal human papillomavirus 16 genomes // Carcinogenesis. 2014. Vol. 35, N 10. P. 2373–2381 doi: 10.1093/carcin/bgu156

[36] Wei L, Griego AM, Chu M, Ozbun MA. Tobacco exposure results in increased E6 and E7 oncogene expression, DNA damage and mutation rates in cells maintaining episomal human papillomavirus 16 genomes. Carcinogenesis. 2014;35(10): 2373–2381. doi: 10.1093/carcin/bgu156

[37] Stumbar SE, Stevens M, Feld Z. Cervical cancer and its precursors: a preventative approach to screening, diagnosis, and management. Prim Care. 2019:46(1):117–134. doi: 10.1016/j.pop.2018.10.011

[38] Stumbar S.E., Stevens M., Feld Z. Cervical cancer and its precursors: a preventative approach to screening, diagnosis, and management // Prim Care. 2019. Vol. 46, N 1. P. 117–134. doi: 10.1016/j.pop.2018.10.011

[39] Stumbar SE, Stevens M, Feld Z. Cervical cancer and its precursors: a preventative approach to screening, diagnosis, and management. Prim Care. 2019:46(1):117–134. doi: 10.1016/j.pop.2018.10.011

[40] Anufrieva VG, Lebedenko EY, Gaida OV, et al. Manageable risk factors for progression of HPV-associated cervical intraepithelial neoplasia. Medical Herald of the South of Russia. 2022;13(2):34–43. EDN: FHPXMW doi: 10.21886/2219-8075-2022-13-2-34-43

[41] Ануфриева В.Г., Лебеденко Е.Ю., Гайда О.В., и др. Управляемые факторы риска прогрессии ВПЧ-ассоциированных цервикальных плоскоклеточных интраэпителиальных неоплазий // Медицинский вестник Юга России. 2022. Т. 13, № 2. С. 34–43. EDN: FHPXMW doi: 10.21886/2219-8075-2022-13-2-34-43

[42] Anufrieva VG, Lebedenko EY, Gaida OV, et al. Manageable risk factors for progression of HPV-associated cervical intraepithelial neoplasia. Medical Herald of the South of Russia. 2022;13(2):34–43. EDN: FHPXMW doi: 10.21886/2219-8075-2022-13-2-34-43

[43] Loopik DL, IntHout J, Melchers WJG, et al. Oral contraceptive and intrauterine device use and the risk of cervical intraepithelial neoplasia grade III or worse: a population-based study. Eur J Cancer. 2020;124:102–109. doi: 10.1016/j.ejca.2019.10.009

[44] Loopik D.L., IntHout J., Melchers W.J.G., et al. Oral contraceptive and intrauterine device use and the risk of cervical intraepithelial neoplasia grade III or worse: a population-based study // Eur J Cancer. 2020. Vol. 124. P. 102–109. doi: 10.1016/j.ejca.2019.10.009

[45] Loopik DL, IntHout J, Melchers WJG, et al. Oral contraceptive and intrauterine device use and the risk of cervical intraepithelial neoplasia grade III or worse: a population-based study. Eur J Cancer. 2020;124:102–109. doi: 10.1016/j.ejca.2019.10.009

[46] Levakov SA, Sheshukova NA, Dabagyan LS. Prevalence and risk factors of cervical intra-epithelial neoplasia. Gynecology, Obstetrics and Perinatology. 2017;16(5):94-100. EDN: ZUKEVJ doi: 10.20953/1726-1678-2017-5-94-100

[47] Леваков С.А., Шешукова Н.А., Дабагян Л.С. Распространённость и факторы риска цервикальных интраэпителиальных неоплазий // Вопросы гинекологии, акушерства и перинатологии. 2017. Т. 16, № 5. С. 94–100. EDN: ZUKEVJ doi: 10.20953/1726-1678-2017-5-94-100

[48] Levakov SA, Sheshukova NA, Dabagyan LS. Prevalence and risk factors of cervical intra-epithelial neoplasia. Gynecology, Obstetrics and Perinatology. 2017;16(5):94-100. EDN: ZUKEVJ doi: 10.20953/1726-1678-2017-5-94-100

[49] Pimple S, Mishra G. Cancer cervix: epidemiology and disease burden. Cytojournal. 2022;19:21. doi: 10.25259/CMAS_03_02_2021

[50] Pimple S., Mishra G. Cancer cervix: epidemiology and disease burden // Cytojournal. 2022. Vol. 19. P. 21. doi: 10.25259/CMAS_03_02_2021

[51] Pimple S, Mishra G. Cancer cervix: epidemiology and disease burden. Cytojournal. 2022;19:21. doi: 10.25259/CMAS_03_02_2021

Funding

Government of the Russian FederationПравительство РФGovernment of the Russian Federation(2023.0708.011)

RIGHTS & PERMISSIONS

Eco-Vector